TY - JOUR
T1 - A Multidimensional Analysis of Physicians' Perceptions of Rx-to-OTC Switched Drug Products
AU - Madhavan, Suresh
AU - Gore, Prasanna
N1 - Funding Information:
Mart?n Pablo Caporgno thanks the Spanish Ministerio de Educaci?n. Cultura y Deporte for his pre-doctoral scholarship (Ref. AP2012-3726). Financial support for this research was provided by the Spanish Ministerio de Educaci?n y Ciencia and FEDER project CTM2011-23069, and by the GEPEA UMR CNRS 6144. The authors also thank the personnel from Ecole des Mines de Nantes, especially the Energy and Environmental Engineering Department, who kindly help during his research stay.
PY - 1994/1/1
Y1 - 1994/1/1
N2 - How do physicians perceive prescription to over-thecounter (Rx-to-OTC) switched drug products vis-his prescription (Rx) and nonprescription (OTC) drug products? Survey data collected from 197 U.S. primary care and internal medicine physicians were used to determine physicians' perceptions of Rx, OTC, and Rx-to-OTC drug products on ten dimensions, including safety; effectiveness; cost; treatment outcomes; and patient, peer, and personal reference. Perceptual mapping indicated that physicians perceived Rx-to-OTC switched drug products to be similar to OTC drug products and occupying a place between Rx and OTC drug products in the minds of physicians. Rx products were perceived to be different from OTC and Rx-to-OTC drug products on all dimensions except safety and side effects. Prescribers of nonprescription and switched products perceived them more favorably than nonprescribers. Older (or experienced), male, high-volume prescribing, general or family practitioner physicians in privale, solo, office-based practice were more likely to have a greater personal preference for Rx drugs. Younger (or less experienced), perhaps female, low-volume prescribing, primary care physicians practicing in the hospital setting were more likely to have a personal preference for switched drug products over prescription drug products.
AB - How do physicians perceive prescription to over-thecounter (Rx-to-OTC) switched drug products vis-his prescription (Rx) and nonprescription (OTC) drug products? Survey data collected from 197 U.S. primary care and internal medicine physicians were used to determine physicians' perceptions of Rx, OTC, and Rx-to-OTC drug products on ten dimensions, including safety; effectiveness; cost; treatment outcomes; and patient, peer, and personal reference. Perceptual mapping indicated that physicians perceived Rx-to-OTC switched drug products to be similar to OTC drug products and occupying a place between Rx and OTC drug products in the minds of physicians. Rx products were perceived to be different from OTC and Rx-to-OTC drug products on all dimensions except safety and side effects. Prescribers of nonprescription and switched products perceived them more favorably than nonprescribers. Older (or experienced), male, high-volume prescribing, general or family practitioner physicians in privale, solo, office-based practice were more likely to have a greater personal preference for Rx drugs. Younger (or less experienced), perhaps female, low-volume prescribing, primary care physicians practicing in the hospital setting were more likely to have a personal preference for switched drug products over prescription drug products.
UR - http://www.scopus.com/inward/record.url?scp=84961425295&partnerID=8YFLogxK
U2 - 10.3109/J058v08n03_02
DO - 10.3109/J058v08n03_02
M3 - Article
AN - SCOPUS:84961425295
SN - 0883-7597
VL - 8
SP - 3
EP - 28
JO - Journal of Pharmaceutical Marketing & Management
JF - Journal of Pharmaceutical Marketing & Management
IS - 3
ER -